Articles

Developments in molecular diagnostics are allowing us to capture an extraordinarily detailed picture of the genomic and other molecular changes that characterise a given tumour specimen. But making best use of the information at our disposal is proving quite a…

Researchers and public policies have historically overlooked the challenges of informal caregiving for cancer patients in Latin America. Now, public health experts are working to profile this neglected group, evaluate their quality of life and put an economic value on…

Hakan Büyükhatipoğlu was at home with his family in Gaziantep at 4.17 in the morning of 6th February when the earthquake struck. The epicentre of that first quake was less than 40 km from the city. Less than 12 hours…

Spinal surgeon Bronek Boszczyk has said that training in complex surgery is like having to learn the violin during a full orchestral concert. The training revolves around closely supervised surgery on real patients in a real operating theatre – which…

Over the past 10 years, immune checkpoint inhibitors (ICIs) have transformed the therapeutic landscape of cancer, becoming standard treatments for metastatic melanoma, renal cell carcinoma, head and neck cancer, and non-small cell lung cancers (NSCLC). “ICIs have revolutionised care in…

Earlier cancer diagnosis could make a huge difference to cancer survival rates – only two in ten of those diagnosed after their cancer has metastasised survive, compared with nine in ten diagnosed when the disease is still localised. In 2020…

Sixteen-year-old Sahil Bacchav had just finished his tenth grade exams when he developed terrible headaches and a feeling that his nose was blocked. He was referred to King Edward Memorial Hospital, a municipal hospital in Mumbai, where he had his…

I make two appointments to speak to Anna Uzlova of Inspiration Family, a Kyiv-based foundation set up in September 2020 to support adult cancer patients. The first time the interview cannot take place because Uzlova is going to visit family…

Miriam Espinoza, a food vendor from Michoacán, Mexico, still remembers the day she received her cancer diagnosis in 2019. After months of waiting for a CT scan and several visits to gynaecologists, who told her that the lump in her…

Doctors at the Tata Memorial Hospital in Mumbai have shown that an ultra-low dose of the immunotherapy drug nivolumab significantly improves survival in patients with recurrent or newly diagnosed head and neck cancers. The findings of the single-centre phase III…